IL33 and glucose measurement: Treating obese mice with IL-33 or IL-25 results in weight loss and increased glucose tolerance, while the opposite effect is observed in mice lacking IL-33, which demonstrates the importance of activated ILC2 for the overall metabolic fitness of the organism (8–10).